Consolidated Statements of Operations - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Revenues
Premiums	$ 49,779	$ 44,945	$ 44,283
Universal life and investment-type product policy fees	5,003	4,974	5,152
Net investment income	22,559	21,273	19,908
Other revenues	2,827	2,601	2,526
Net investment gains (losses)	(1,145)	(1,184)	(2,824)
Net derivative gains (losses)	(1,939)	(1,623)	(2,140)
Total revenues	77,084	70,986	66,905
Expenses
Policyholder benefits and claims	49,718	44,728	44,590
Policyholder liability remeasurement (gains) losses	(150)	(206)	(45)
Market risk benefit remeasurement (gains) losses	(508)	(1,109)	(994)
Interest credited to policyholder account balances	8,950	8,339	7,860
Policyholder dividends	553	595	622
Other expenses	13,860	13,017	12,710
Total expenses	72,423	65,364	64,743
Income (loss) before provision for income tax	4,661	5,622	2,162
Provision for income tax expense (benefit)	1,258	1,178	560
Net income (loss)	3,403	4,444	1,602
Less: Net income (loss) attributable to noncontrolling interests	24	18	24
Net income (loss) attributable to MetLife, Inc.	3,379	4,426	1,578
Less: Preferred stock dividends	194	200	198
Preferred Stock Redemption Premium	12	0	0
Net income (loss) available to MetLife, Inc.’s common shareholders	$ 3,173	$ 4,226	$ 1,380
Net income (loss) available to MetLife, Inc.’s common shareholders per common share:
Basic	$ 4.74	$ 5.98	$ 1.82
Diluted	$ 4.71	$ 5.94	$ 1.81